{
    "company_name": "AVECHO BIOTECHNOLOGY LIMITED",
    "address": "Unit A8, 2A Westall Road, CLAYTON, VIC, AUSTRALIA, 3168",
    "summary": "Avecho is focused on developing and commercialising innovative Human Health, Animal Health and Personal Care products using its proprietary drug delivery system, TPM.",
    "details": "Avecho is focused on developing and commercialising innovative Human Health, Animal Health and Personal Care products using its proprietary drug delivery system, TPM.",
    "website": "http://avecho.com.au/",
    "stock_code": "AVE",
    "links": "['https://avecho.com.au', '#search', '#navigation', 'https://avecho.com.au/about-us/', 'https://avecho.com.au/about-us/', 'https://avecho.com.au/about-us/board-and-leadership/', 'https://avecho.com.au/tpm-technology/', 'https://avecho.com.au/portfolio/', 'https://avecho.com.au/portfolio/pipeline/', 'https://avecho.com.au/portfolio/cannabinoids/', 'https://avecho.com.au/portfolio/pharmaceutical/', 'https://avecho.com.au/portfolio/animal-health/', 'https://avecho.com.au/portfolio/manufacturing/', 'https://avecho.com.au/', 'https://avecho.com.au/investor-centre/', 'https://avecho.com.au/investor-centre-old/news/', 'https://avecho.com.au/contact-us/', '#', 'https://avecho.com.au/tpm-technology/', 'http://cbdinsomniastudy.com/', 'https://avecho.com.au/markets/pharmaceutical/', 'https://avecho.com.au/markets/pharmaceutical/', 'https://avecho.com.au/markets/pharmaceutical/', 'https://avecho.com.au/markets/animal-health/', 'https://avecho.com.au/markets/animal-health/', 'https://avecho.com.au/markets/animal-health/', 'https://avecho.com.au/markets/manufacturing/', 'https://avecho.com.au/markets/manufacturing/', 'https://avecho.com.au/markets/manufacturing/', 'https://avecho.com.au/investor-centre/news/2024/03/28/media-channel-9-news/', 'https://avecho.com.au/investor-centre/news/2024/03/28/media-channel-9-news/', 'https://avecho.com.au/investor-centre/news/2024/03/26/avechos-phase-iii-clinical-trial-for-insomnia-commences/', 'https://avecho.com.au/investor-centre/news/2024/03/26/avechos-phase-iii-clinical-trial-for-insomnia-commences/', 'https://avecho.com.au/investor-centre/news/2024/03/14/avecho-completes-meeting-with-tga-confirming-pathway-for-phase-iii-clinical-trial/', 'https://avecho.com.au/investor-centre/news/2024/03/14/avecho-completes-meeting-with-tga-confirming-pathway-for-phase-iii-clinical-trial/', 'https://avecho.com.au/about-us/', 'https://avecho.com.au/about-us/', 'https://avecho.com.au/about-us/board-and-leadership/', 'https://avecho.com.au/contact-us/', 'https://avecho.com.au/tpm-technology/', '#', 'https://avecho.com.au/portfolio/', 'https://avecho.com.au/portfolio/pharmaceutical/', 'https://avecho.com.au/portfolio/animal-health/', 'https://avecho.com.au/portfolio/manufacturing/', 'https://avecho.com.au/portfolio/pipeline/', 'https://avecho.com.au/', 'https://avecho.com.au/', 'https://avecho.com.au/investor-centre-old/news/', 'https://www.linkedin.com/company/phosphagenics-ltd.', 'https://www.youtube.com/channel/UCFdd2Raufzr1TOnYqdeb_zQ', 'https://twitter.com/AvechoLtd', '/terms-of-use', '/privacy-policy', 'https://avecho.com.au']",
    "images": "https://avecho.com.au/wp-content/uploads/Logos/Avehco_Logo.svg, https://avecho.com.au/wp-content/uploads/Logos/Avehco_Logo_Reversed.svg, https://avecho.com.au/wp-content/uploads/homepage/homepage-header.jpg, https://avecho.com.au/wp-content/uploads/homepage/homepage-brandmark.png, https://avecho.com.au/wp-content/uploads/Icons/icon-pharmaceutical.png, https://avecho.com.au/wp-content/uploads/Icons/icon-animal-care.png, https://avecho.com.au/wp-content/uploads/Icons/icon-personal-care.png, https://avecho.com.au/wp-content/uploads/Logos/Avehco_Logo_Reversed.svg",
    "company_logo_link": "https://avecho.com.au/wp-content/uploads/Logos/Avehco_Logo.svg"
}